<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis Studies in three families</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Kumaraswamy</forename><surname>Sivakumar</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Christina</forename><surname>Semino-Mora</surname></persName>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Marinos</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
						</author>
						<author>
							<persName><surname>Building</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Neuromuscular Diseases Section</orgName>
								<orgName type="department" key="dep2">National Institutes for</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Neurological Disorders and Stroke</orgName>
								<orgName type="institution" key="instit1">National Institutes of Room 4N248</orgName>
								<orgName type="institution" key="instit2">National Institutes of Health</orgName>
								<address>
									<postCode>20892</postCode>
									<settlement>Bethesda, Bethesda</settlement>
									<region>Health, Maryland, MD</region>
									<country>USA, USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis Studies in three families</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">54C3DEDB8E7FB02CE8539C32718FB1E3</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>myositis, HLA antigens</term>
					<term>autoimmune disease</term>
					<term>inclusion body myositis</term>
					<term>inherited susceptibility CK ϭ creatine kinase</term>
					<term>f-IBM ϭ familial inclusion body myositis</term>
					<term>h-IBM ϭ hereditary inclusion body myopathy</term>
					<term>HLA ϭ histocompatability leukocyte antigen</term>
					<term>MHC ϭ major histocompatability complex</term>
					<term>s-IBM ϭ sporadic inclusion body myositis</term>
					<term>TNF-α ϭ tumournecrosis factor-α</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>We describe the occurrence of an inflammatory inclusion the presence of the DR3 allele (DRB1*0301/0302) in all seven patients. The combination of the clinical, histological, body myositis in siblings of a single generation in three separate families. The disease in this total of seven patients immunopathological and immunogenetic features indicate that these patients have a disease identical to sporadic was characterized by selective and early involvement of forearm and finger flexors, confirmed by MRI, and inclusion body myositis (s-IBM). We conclude that the classic, inflammatory, s-IBM can also occur in families weakness of the quadriceps, triceps and foot extensors. Muscle biopsies in at least two members from each family (familial inclusion body myositis), in a pattern analogous to the familial occurrence of other autoimmune neuro-showed endomysial inflammation, red-rimmed vacuoles, intracellular amyloid deposition and 15-18-nm tubulo-logical diseases such as myasthenia gravis and multiple sclerosis. These observations strengthen the view that s-IBM filaments within the vacuolated muscle fibres. Immunocytochemistry on serial muscle biopsy sections demonstrated behaves like other autoimmune diseases and has disease susceptibility linked to the DR3 allele. an abundance of CD8ϩ cells invading non-necrotic, MHC-I-expressing muscle fibres. Immunogenetic studies showed</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Sporadic inclusion body myositis (s-IBM) is a chronic, heterogenous group of non-inflammatory, red-rimmed vacuolar myopathies that represent various clinical acquired, inflammatory myopathy that (i) usually begins phenotypes which are always distinct from the typical after the age of 50 years, (ii) affects proximal and distal clinical picture of s-IBM <ref type="bibr">(Cole et al., 1988</ref>; Klingman muscle groups with a characteristic early involvement of and Gibbs, 1991; <ref type="bibr">Neville et al., 1992;</ref><ref type="bibr" target="#b2">Sadeh et al., 1993</ref>; finger flexors and quadriceps muscles and (iii) has <ref type="bibr" target="#b8">Sivakumar and Dalakas, 1996)</ref>. characteristic histological features of red-rimmed vacuoles</p><p>We now describe three separate families in which the containing 15-18-nm tubulofilaments, small intracellular classic clinicohistological picture of s-IBM was observed in amyloid deposits, and primary endomysial inflammation a total of seven siblings. In all families, the disease [familial with CD8ϩ cells and macrophages invading non-necrotic inclusion body myositis (f-IBM)] affected only one muscle fibres <ref type="bibr" target="#b2">(Lotz et al., 1989;</ref><ref type="bibr">Dalakas, 1991;</ref><ref type="bibr">Sekul and generation. Dalakas, 1993;</ref><ref type="bibr">Griggs et al., 1995)</ref>. In contrast, hereditary inclusion body myopathies (h-IBMs) comprise a </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Family A</head><p>biopsies in both patients revealed histological, Two brothers, aged 78 and 73 years and born in the Midwest immunopathological and electron microscopic features of the USA, developed symptoms of proximal and distal typical of s-IBM, as described below. muscle weakness in the lower extremities and frequent falls due to knee-buckling, at the age of 73 and 69 years, respectively. The older brother also developed weakness of the forearm flexors and swallowing difficulties. A muscle</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Family B</head><p>Two brothers (Fig. <ref type="figure" target="#fig_0">1</ref>), aged 69 and 63 years, developed biopsy was diagnostic of IBM <ref type="bibr" target="#b2">(Lotz et al., 1989)</ref> and both patients were referred to the NIH (National Institutes of weakness and wasting of the quadriceps muscle and the flexor compartment of the forearm in their mid-fifties. In Health). None of the other family members (Fig. <ref type="figure" target="#fig_0">1</ref>) had symptoms of a myopathy. On admission, neurological the older brother, the symptoms began in the lower extremities with frequent falls and weakness in ambulation; examination revealed, in both brothers, wasting and weakness of the quadriceps muscles (Fig. <ref type="figure" target="#fig_1">2</ref>), atrophy and weakness of in the younger brother the symptoms began in the upper extremities with weakness of the grip. Subsequently, both the finger flexors and weakness of foot extensors, as classically seen in s-IBM <ref type="bibr">(Dalakas, 1991;</ref><ref type="bibr">Sekul et al., 1994)</ref>.</p><p>brothers developed the classic features of s-IBM with severe involvement of the quadriceps, forearm flexors, triceps and There was no history of myotoxic drug use, infections or any systemic disease. The serum creatine kinase (CK) level foot extensors. No bulbar or respiratory symptoms were noted. By the time the patients were seen at the NIH, was 167 and 426 U/l (normal; 52-386 U/l). An elevated CK the older brother was wheelchair-bound but the younger brother was still ambulatory. Their CK levels were 522 and 980 U/l, respectively. Muscle biopsy in both patients had all the histological and immunopathological features of s-IBM, as described below.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Family C</head><p>Three siblings of an African-American family (Fig. <ref type="figure" target="#fig_0">1</ref>), two men aged 73 and 69 years and a woman aged 77 years, developed a myopathy with an identical pattern of muscle involvement. The two men developed proximal lower extremity weakness, quadriceps wasting and frequent falls in their early sixties, followed, a few years later, by weakness in the distal muscles of the upper extremities. Muscle biopsy in both male patients showed the typical histological features of s-IBM. Their sister (CI) developed weakness in the lower extremities at the age of 48 years, and developed slowly thereafter weakness and wasting in the proximal and distal muscles of the upper and lower extremities. None of the in all three siblings but was more prominent in the older brother and sister who both had difficulty making a fist (Fig. <ref type="figure" target="#fig_2">3</ref>). Overall, in the upper extremities, the weakness was</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Special studies</head><p>(i) T 1 -weighted MRIs of the thigh muscles were performed predominantly distal but both the proximal and the distal muscles were equally affected in the lower extremities. Mild in Family C, to confirm the selective and prominent involvement of the knee extensor muscles. The MRIs of facial-and neck-flexor weakness were present in all three patients. When seen at the NIH, the older brother (CII) had the quadriceps were compared with the studies previously performed in patients with s-IBM and h-IBM (Sivakumar also developed dysphagia. CK levels were 359 and 434 in the men and 124 U/l in the woman. As described below, the and Dalakas, 1996).</p><p>(ii) Open muscle biopsies were performed and processed previous and repeated biopsies in the two brothers revealed features identical to those seen in patients with s-IBM.</p><p>for muscle-enzyme histochemistry and Congo-red staining.</p><p>Glutaradehyde-fixed and Epon-embedded tissue as well as frozen sections <ref type="bibr">(Askanas et al., 1991)</ref> were used for electron microscopy. In addition, immunocytochemistry was performed on serial, 5-µm sections, of the muscle biopsy specimens, utilizing monoclonal antibodies directed against major histocompatability complex (MHC) class I antigen, CD8ϩ cells, macrophages, CD4ϩ cells and Natural Killer cells (Leu 19) in an immunoperoxidase technique, as described by <ref type="bibr">Illa et al. (1992)</ref>. Disease control biopsies, run concurrently with the above sections, included muscle specimens from a patient with typical histological features of s-IBM and a patient with the autosomal dominant form of h-IBM <ref type="bibr" target="#b8">(Sivakumar and Dalakas, 1996)</ref>.</p><p>(iii) Histocompatability leukocyte antigen (HLA) Class II genotyping was performed using PCR (polymerase chain reaction) amplification with sequence-specific primers <ref type="bibr">(Park and Tonai, 1992)</ref> to determine if the predominance of DR3 haplotype, seen in patients with s-IBM <ref type="bibr">(Garlepp et al., 1994)</ref>, was also present in the studied patients.</p><p>(iv) Complete haematological, biochemical and serological studies were performed including a search for anti-nuclear antibodies, and antibodies against double-stranded DNA, ribonucleoprotein, Jo-1, SS-A and SS-B.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MRI findings</head><p>MRI performed in one family showed that the extensor compartment of the thighs was more significantly involved than the flexor compartment (Fig. <ref type="figure" target="#fig_3">4</ref>), as typically seen in s-IBM <ref type="bibr">(Sekul and Dalakas, 1993)</ref>. The same pattern was seen clinically as marked wasting of the quadriceps muscle in the other two families (Fig. <ref type="figure" target="#fig_1">2</ref>). In Patient II of Family C, who had advanced disease, the flexor compartment was also involved (Fig. <ref type="figure" target="#fig_3">4</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histology</head><p>The muscle biopsies on all patients showed a myopathy with variation of fibre size, hypertrophic and small fibres, and increased connective tissue. Red-rimmed vacuoles, intramyofibre amyloid deposits, ragged-red fibres and primary Family C (Fig. <ref type="figure">5</ref>). Patient CII had two muscle biopsies, one due to fatty replacement. The third member of this family (Patient CII), with advanced, end-stage disease, has involvement of both from the least affected deltoid muscle that showed nonthe quadriceps and the hamstring muscle groups. specific myopathic features and another from the more affected quadriceps muscle that showed all the diagnostic 15-18 nm diameter tubulofilaments were observed in the features of an inflammatory inclusion body myositis, as noted muscle biopsy of at least one representative member (AI, above. In Patient CI, who had the same typical phenotype AII, BII and CIII) from each family (Fig. <ref type="figure">5</ref>). of s-IBM as her two brothers (Figs <ref type="figure" target="#fig_3">3 and 4</ref>), muscle biopsy performed from the least affected deltoid muscle revealed non-specific myopathic features, similar to the deltoid muscle</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunocytochemistry</head><p>The predominant endomysial cells were CD8ϩ cells which biopsy of her brother (CII) (probable IBM). However, she did not receive any further biopsies. By electron microscopy, surrounded or invaded non-necrotic and MHC-I antigen-Fig. <ref type="figure">5</ref> Cross-section of a trichromatically stained muscle biopsy from Patient AI (A) shows primary endomysial inflammation and vacuolated fibres (ϫ425). Electron microscopy, performed of a redrimmed-vacuolated muscle fibre of the same patient, identified by the Gomori trichrome stain (B inset, ϫ400), reveals the characteristic tubulofilaments of 15-18 nm diameter (ϫ30 000, bar represents 160 nm).</p><p>expressing muscle fibres (Fig. <ref type="figure" target="#fig_4">6</ref>). The other cells were (Fig. <ref type="figure" target="#fig_5">7A and B</ref>), as previously described <ref type="bibr" target="#b8">(Sivakumar and Dalakas, 1996)</ref>. macrophages and CD4ϩ cells. Natural killer cells were not detected. The MHC class I antigen was expressed in most fibres, even in areas without inflammation (Fig. <ref type="figure" target="#fig_4">6B</ref>), in a pattern identical to the one seen in s-IBM (Engel and Arahata,</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunogenetic studies.</head><p>1984). In contrast, in the concurrently stained sections of a</p><p>The DRB1*0301/0302 allele corresponding to the DR3 haplotype was seen in all affected members (Table <ref type="table">1</ref>). No patient with h-IBM, MHC class I antigen was not expressed autoantibodies were detected, except for a positive anti-These observations indicate that the typical s-IBM, with immunopathological features of an autoimmune process, can nuclear antibody titre (1:160), with a speckled pattern, observed in the older brother of Family A (Patient A1).</p><p>be also familial, affecting more than one sibling of a generation.</p><p>The observed familial occurrence of an inflammatory, and probably autoimmune, inclusion body myositis (f-IBM) needs</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>to be distinguished from the hereditary inclusion body At least two siblings in three different families had the myopathies (h-IBM), a heterogenous group of vacuolar typical clinical phenotype and the radiological, histological, myopathies without inflammatory or immunopathological ultrastructural and inflammatory features of s-IBM with features that often occur in more than one generation of a prominent endomysial CD8ϩ cytotoxic T cells invading MHC class I antigen-expressing non-necrotic muscle fibres.</p><p>family, or have predilection for certain ethnic groups (Askanas and <ref type="bibr">Engel, 1995;</ref><ref type="bibr" target="#b8">Sivakumar and Dalakas, 1996)</ref>. Although pernicious anaemia and common variable immunodeficiency, while other autoimmune diseases including autoimmune the phenotype of patients with h-IBM is variable <ref type="bibr" target="#b8">(Sivakumar and Dalakas, 1996)</ref>, these patients do not have the selective thyroiditis, myasthenia gravis and pernicious anaemia can occur in their relatives <ref type="bibr">(Rugero et al., 1995)</ref>. Some siblings pattern of involvement of the quadriceps and the long finger flexor muscles, as typically seen in s-IBM.</p><p>or relatives of patients with neurological diseases of putative or definite autoimmune origin, e.g. multiple sclerosis, The immunopathological features observed in the present familial cases are identical to those seen in s-IBM and in myasthenia gravis and polymyositis <ref type="bibr">(Cook et al., 1963;</ref><ref type="bibr">Leukonia and Buxton, 1973)</ref>, also demonstrate a variety polymyositis where an autoimmune pathogenesis has been strongly considered <ref type="bibr">(Engel and Arahata, 1984;</ref><ref type="bibr" target="#b2">Engel et al.,</ref> of autoantibodies and develop an unrelated (or the same) autoimmune disease. The present observations that IBM with 1994). s-IBM has been associated with other autoimmune conditions, e.g. Sjogrens disease, dermatitis herpetiformis, prominent inflammatory features can also occur in siblings,</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc>Fig.1Pedigrees of Families A-C. In each family there are two (Families A and B) or three (Family C) siblings in only one generation affected with inflammatory IBM that presented with a phenotype identical to s-IBM.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2</head><label>2</label><figDesc>Fig. 2 Photographs of anterior thighs in siblings with inflammatory IBM. Two brothers from Family A demonstrate the selective atrophy of the quadriceps muscle, as typically seen in s-IBM.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3</head><label>3</label><figDesc>Fig. 3 Photographs of forearms and hands in siblings with</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 4</head><label>4</label><figDesc>Fig. 4 T 1 -weighted MRIs of the thighs in siblings with</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 6</head><label>6</label><figDesc>Fig. 6 Endomysial CD8ϩ cells in the MHC class I antigen-expressing muscle fibres in f-IBM. Serial sections of a muscle biopsy from Patient BI of Family B immunostained with antibodies to CD8ϩ cells (A) and MHC class I antigen (B) (ϫ425). CD8ϩ cells invade MHC-I-expressing muscle fibres. In addition, MHC-I is present in fibres not surrounded by cells.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 7</head><label>7</label><figDesc>Fig. 7 Expression of MHC class I antigen in low-magnification field in the muscle biopsies of patients with f-IBM (A) compared with h-IBM (B). Muscle biopsy of Patient CIII immunostained for MHC-I(A) demonstrates the ubiquitous expression of the MHC-I antigen in many fibres. Several foci of inflammatory cells invading these fibres are also noted (ϫ270). In a concurrently immunostained section from a control patient with h-IBM (B), no MHC-I-stained fibres are seen (ϫ350).</figDesc></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1 Alleles in HLA II antigens seen in affected</head><p>The observed similarities between inflammatory f-IBM siblings of inflammatory f-IBM and s-IBM, prompted us to treat the f-IBM with the same therapeutic strategies used in s-IBM. Many autoimmune diseases have been associated with a particular HLA antigen and the susceptibility to autoimmunity Cole AJ, Kuzniecky R, Karpati G, Carpenter S, Andermann E, has been linked to various MHC-associated genes. In Andermann F. Familial myopathy with changes resembling inclusion polymyositis and dermatomyositis, there is a high incidence body myositis and periventricular leucoencephalopathy. <ref type="bibr">Brain 1988;</ref><ref type="bibr">111: 1025-37.</ref> (42%) of the DR3 phenotype <ref type="bibr">(Love, 1989)</ref>. A very significant (92%) incidence of the HLA DR3 phenotype, com-Cook CD, Rosen FS, Banker BQ. Dermatomyositis and focal pared with 25% in the control population, has been found in scleroderma. Pediatr Clin North Am 1963; 10: 979-1016. s-IBM <ref type="bibr">(Garlepp et al., 1994)</ref>. We also found the same strong as autoimmune hepatitis, agranulocytosis and inflammatory bowel disease <ref type="bibr">(Satsangi et al., 1996)</ref>, the noted association Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polysuggests that the sporadic and the familial forms of inflammyositis and inclusion body myositis. Ann <ref type="bibr">Neurol 1984;</ref><ref type="bibr">16: 209-15.</ref> matory IBM share the same inherited determinants of susceptibility to the inflammatory process. Based on the clinicopathological and immunogenetic features of our patients with f-IBM, which resemble the s-Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated IBM, we have argued that the pathogenesis may be related differences in production of tumor necrosis factor-α: relevance to to an increased genetic susceptibility to the autoimmune genetic predisposition to systemic lupus erythematosus. Proc Natl process. However, because of the possibility that members Acad <ref type="bibr">Sci USA 1990;</ref><ref type="bibr">87: 1233-7</ref> in the next generation may also develop the same lateonset disease, other modes of disease inheritance cannot be Klingman JG, Gibbs MA. Familial inclusion body myositis <ref type="bibr">[abstract]</ref>. Neurology 1991; 41 Suppl 1: 275. excluded.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Association of inclusion body myositis with autoimmune diseases and auto-antibodies</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Lewkonia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ph</forename><forename type="middle">;</forename><surname>Buxton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rugiero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Koffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>Myositis in father and daughter. abstract</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Neurol Neurosurg Psychiatry</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page">333</biblScope>
			<date type="published" when="1973">1973. 1995</date>
		</imprint>
	</monogr>
	<note>Ann Neurol</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Vacuolar myopathy body myositis: observations in 40 patients</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Lotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wj</forename><forename type="middle">Inclusion</forename><surname>Litchy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gadoth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hadar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ben-David E ;</forename><surname>Satsangi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Welsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">I</forename><surname>Bunce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Julier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Farrant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename></persName>
		</author>
		<idno>217-32. 727-747</idno>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<date type="published" when="1989">1989. 1993</date>
		</imprint>
	</monogr>
	<note>Brain</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Cronin susceptibility and disease phenotype in inflammatory bowel disease ME. Current concepts in the idiopathic inflammatory myopathies</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Leff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page">1198</biblScope>
			<date type="published" when="1996">1996. 1996</date>
		</imprint>
	</monogr>
	<note>Comment in: Lancet polymyositis, dermatomyositis, and related disorders</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: new concepts</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Sekul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="148" to="150" />
			<date type="published" when="1989">1989. 1989</date>
		</imprint>
	</monogr>
	<note>Ann Intern Med</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Semin Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="256" to="263" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Neville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Baumbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Ringel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sujansky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sekul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Magnetic resonance imaging</title>
		<imprint>
			<publisher>MRI</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Familial inclusion body myositis: evidence for autosomal of the forearm as a diagnostic aid in patients with inclusion body dominant inheritance</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Garcia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">A130</biblScope>
			<date type="published" when="1992">1992. 1994</date>
			<publisher>IBM</publisher>
		</imprint>
	</monogr>
	<note>Neurology. Suppl</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The spectrum of familial inclusion Park SM, Tonai R. Phenotype frequencies of the class II (DR, DQ) body myopathies in 13 families and a description of a quadriceps-DNA alleles by the pattern of sequence-specific primer mixtures sparing phenotype in non-Iranian Jews</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="977" to="984" />
			<date type="published" when="1992">1992. 1996</date>
		</imprint>
	</monogr>
	<note>Neurology</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">in four different populations and probable haplotypes between DRB1 allele and DQB1 allele</title>
	</analytic>
	<monogr>
		<title level="m">Clinical transplants. California: UCLA Tissue Typing Received</title>
				<editor>
			<persName><forename type="first">P</forename><surname>Terasaki</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Ceka</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="1996-09-26">September 26. 1996. November 7, 1996. November 25. 1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Laboratory</title>
		<imprint>
			<biblScope unit="page" from="475" to="500" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
